Global Health & Medicine

Sekihara K, Shibasaki T, Okamoto T, Matsumoto C, Ito K, Fujimoto K, Kato F, Matsuda W, Kobayashi K, Sasaki R, Uemura T, Kimura A, Sugiyama H, Kokudo N

Global Health & Medicine. 2022; 4(2):122-128.

DOI: 10.35772/ghm.2021.01121

Impact of prioritized vaccinations for the elderly on the COVID-19 pandemic in Japan

Nomoto H, Hayakawa K, Ohmagari N

Global Health & Medicine. 2022; 4(2):129-132.

DOI: 10.35772/ghm.2022.01015

The first eleven cases of SARS-CoV-2 Omicron variant infection in Japan: A focus on viral dynamics

Okumura N, Tsuzuki S, Saito S, Saito T, Takasago S, Hojo M, Iwamoto N, Ohmagari N

Global Health & Medicine. 2022; 4(2):133-136.

DOI: 10.35772/ghm.2021.01124

Promotion of proper use of anti-SARS-CoV-2 drugs and SARS-CoV-2 vaccines by hospital pharmacists and establishment of an adverse drug reaction reporting system

Seto K, Ohashi Y, Masuda J, Terakado H

Global Health & Medicine. 2022; 4(2):137-140.

DOI: 10.35772/ghm.2022.01024

Adverse reactions and attitudes toward vaccines among young populations one month after receiving a second dose of mRNA-1273 in Japan

Matsumoto N, Higuchi C, Mitsuhashi T, Hagiya H, Takao S, Yorifuji T

Global Health & Medicine. 2022; 4(2):141-143.

DOI: 10.35772/ghm.2021.01125

Establishment of an emergency regulatory approval system in Japan in response to the COVID-19 pandemic and challenges in developing domestically produced vaccines

Ujiie M

Global Health & Medicine. 2022; 4(2):144-145.

DOI: 10.35772/ghm.2022.01023

COVID-19 in Japan: An update on national policy, research, clinical practice, and vaccination campaign

How did the Tokyo Metropolitan Government respond to COVID-19?

Reporting on the implementation to set up a "care and isolation facility" for mild COVID-19 cases in Tokyo

Public health responses to COVID-19 in Japan

Long COVID: current status in Japan and knowledge about its molecular background

For safe and adequate blood purification therapy in severe COVID-19 ‒ what we have learned so far

Cardiovascular considerations during the COVID-19 pandemic: A focused review for practice in Japan

Change in cancer diagnosis during the COVID-19 pandemic: Trends estimated from FDG-PET/CT

Trends in endotracheal intubation for patients with COVID-19 by emergency physicians

Poor prognosis of patients with severe COVID-19 admitted to an infectious disease intensive care unit during the pandemic caused by the Delta variant in Japan

Impact of prioritized vaccinations for the elderly on the COVID-19 pandemic in Japan

The first eleven cases of SARS-CoV-2 Omicron variant infection in Japan: A focus on viral dynamics

Promotion of proper use of anti-SARS-CoV-2 drugs and SARS-CoV-2 vaccines by hospital pharmacists and establishment of an adverse drug reaction reporting system

Adverse reactions and attitudes toward vaccines among young populations one month after receiving a second dose of mRNA-1273 in Japan

Establishment of an emergency regulatory approval system in Japan in response to the COVID-19 pandemic and challenges in developing domestically produced vaccines

Links